Webinar: ADC鈥檚 Are Back Stronger Than Ever: How, Why & What鈥檚 Next
Summary: Antibody-drug conjugates (ADCs) have achieved commercial success over the last ten years. ADCs offer the prospect of more precise treatments and a reduction in off-target effects, however challenges including instability remain. In this on-demand presentation, Mike Riley, President, 天美影院 Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from 天美影院鈥檚 award-winning SMARTag庐 ADC platform.